![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/06/22/2251174/0/en/NuGenerex-Immuno-Oncology-Secures-535-Million-Valuation-from-World-Class-Independent-Valuation-Appraisal-Firm.html
http://www.globenewswire.com/news-release/2020/11/23/2131844/0/en/Generex-and-NuGenerex-Immuno-Oncology-Ii-Key-SARS-CoV-2-Vaccine-Partner-Bintai-Kinden-Executes-its-Exclusive-Distribution-Licensing-Option-for-Australia-and-New-Zealand.html
https://www.nasdaq.com/press-release/nugenerex-immuno-oncology-announces-closing-of-a-licensing-distribution-agreement